Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease. Nguyen HV, Mital S, Knopman DS, Alexander GC, et al. Neurology 2024;102:e209218.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nguyen HV, Mital S, Knopman DS, Alexander GC, et al. Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease. Neurology 2024;102:e209218.
PMID: 38484190